Company News

Share this article:
FDA's Vaccines and Related Biological Products Advisory Committee gave GlaxoSmithKline's Cervarix a favorable recommendation yesterday, and also recommended that Merck's Gardasil receive an indication for boys and men. FDA is not obligated to follow the recommendation of its advisory committees, though it usually does. Cervarix has not yet been approved in the US. Gardasil was approved for women and girls in 2006.

Salix Pharmaceuticals received an FDA approval for Metozolv (metoclopramide), a treatment for diabetic gastroparesis and gastroesophageal reflux disease (GERD). The drug was approved for short-term use, from four to 12 weeks.
 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.